text.skipToContent text.skipToNavigation

Ibidi , µ-Slide VI 0.4 µ-Pattern RGD Test Patterns 2: #1.5 polymer coverslip, micropatterned surface with RGD motif, 6 patterns, surface passivation with Bioinert, sterilized, individually packed, 83652

ibidi GmbH -- Item TECPIM000164060
Please add to cart & request for quote to see the price
Longer Lead Time

The Ibidi µ-Slide VI 0.4 µ-Pattern RGD Test Patterns 2 is a high-quality polymer coverslip that features a micropatterned surface with an RGD motif. It comes with 6 different test patterns and is individually packed, sterilized, and surface passivated with Bioinert.

- Benefits/Advantages:

- Precision: The micropatterned surface with RGD motif provides precise and uniform microstructural features for cellular experiments.

- Versatility: The 6 different test patterns allow for various experimental setups and enable researchers to study cell behavior in different conditions.

- Convenience: Each coverslip is individually packed and sterilized, ensuring ease of use and maintaining sterility during experiments.

- Reliable Results: The surface passivation with Bioinert minimizes non-specific cell interactions, ensuring accurate and reliable experimental outcomes.

Product Details

Model
Product Type Consumables
Part Number 83652
Brand ibidi GmbH
Gross Dimensions (WxDxH cm)
Net Dimensions (WxDxH cm)
Gross Weight (kg)
Net Weight (kg)

More options are available. Please contact us for more information.

ibidi GmbH

ibidi is a leading global supplier for functional cell-based assays and advanced products for cellular microscopy. A shared passion among the team for innovation, quality, service and a strong relationship to the customers, are the keys to ibidi's excellence and success.

ibidi is committed to supplying the highest quality products and service at a good value. Its innovative research tools enabling scientists to achieve outstanding success and breakthroughs in life sciences, pharma, biotechnology, and medical diagnostics. ibidi’s goal is to provide scientists with standardized workflows that result in reproducible and truly objective scientific data, which can also be translated into therapies.